HomeStock ScreenerSudarshan Pharma Industries

Sudarshan Pharma Industries Share Price | Sudarshan Pharma Industries Stock Screener

SUDARSHAN Dyes & Pigments
Track Sudarshan Pharma Industries share price live with TickJournal's free stock screener. Check SUDARSHAN price range for the annual price range and momentum. Use the Sudarshan Pharma Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sudarshan Pharma Industries Market Cap ₹830.28 Cr.
SUDARSHAN P/E Ratio (TTM) 34.58
Sudarshan Pharma Industries P/B Ratio 5.32
EPS (TTM) ₹0.97
Dividend Yield -
Debt to Equity 1.13
SUDARSHAN 52 Week High -
Sudarshan Pharma Industries 52 Week Low -
Operating Margin 9.00%
Profit Margin 4.89%
SUDARSHAN Revenue (TTM) ₹225.00
EBITDA ₹24.00
Net Income ₹11.00
Total Assets ₹642.00
Total Equity ₹155.00

Sudarshan Pharma Industries Share Price Chart

Screen Sudarshan Pharma Industries share price with an interactive chart. Analyse SUDARSHAN price trends and volatility across different timeframes.

Sudarshan Pharma Industries Company Profile - Fundamental Screener

Screen Sudarshan Pharma Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUDARSHAN shares.
Sector Chemicals
Industry Dyes & Pigments
Sub-Sector Dyes & Pigments
Segment E
ISIN INE00TV01023

Sudarshan Pharma Industries Balance Sheet Screener

Screen SUDARSHAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020
Assets
Total Assets 642 402 283 233 138 99 58
Current Assets 490 335 237 199 130 88 47
Fixed Assets 102 24 26 20 7 6 6
Liabilities
Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 29 11 11 13 5 6 7
Non-Current Liabilities 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 155 132 112 101 30 23 20
Share Capital 24 24 24 24 10 10 10
Reserves & Surplus 131 104 88 77 20 13 10

Sudarshan Pharma Industries Income Statement Screener - Profit & Revenue Analysis

Screen Sudarshan Pharma Industries income statement and profit fundamentals. Analyze SUDARSHAN quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sudarshan Pharma Industries share price evaluation.
Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar
Revenue 225 170 171 147 162 116 129 100 232
Expenses 201 157 160 134 147 108 117 97 217
EBITDA 24 12 11 12 15 9 12 3 15
Operating Profit % 9.00% 6.00% 5.00% 8.00% 9.00% 7.00% 9.00% 2.00% 6.00%
Depreciation 1 1 1 1 1 1 1 1 1
Interest 8 6 6 6 4 4 4 4 6
Profit Before Tax 16 5 4 5 10 4 8 -2 9
Tax 4 1 0 1 3 1 2 0 2
Net Profit 11 4 4 4 7 3 6 -1 7
EPS 0.48 0.18 0.16 0.16 0.29 0.12 0.24 -0.05 0.27

Sudarshan Pharma Industries Cash Flow Screener - Liquidity Fundamentals

Screen SUDARSHAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March
Operating Activities 35 8 -29 -4 3 1
Investing Activities -20 -7 -26 -2 -1 -3
Financing Activities -14 -12 66 4 -2 0
Net Cash Flow 0 -12 12 -1 0 -2

Sudarshan Pharma Industries Shareholding Pattern Screener

See Sudarshan Pharma Industries shareholding pattern with promoter, FII, and DII holdings. Check Sudarshan Pharma Industries promoter holding and ownership changes for SUDARSHAN on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Sept 2023-Mar
Promoter Holding 57.39% 57.39% 57.39% 57.39% 57.39% 57.39% 57.39% 57.39%
FII Holding 19.95% 18.45% 19.48% 20.79% 19.78% 1.40% 13.07% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.05% 0.00% 0.05% 0.05% 0.05% 0.00% 0.00% 0.00%
Public Holding 16.41% 18.18% 17.14% 16.30% 16.88% 23.61% 23.20% 20.35%
Other Holding 6.20% 5.98% 5.94% 5.46% 5.90% 17.59% 6.33% 22.26%
Shareholder Count 1,346 1,212 1,327 1,383 1,407 913 787 2,785

Sudarshan Pharma Industries Share Dividend Screener - Share Yield Analysis

Check Sudarshan Pharma Industries dividend history with payout and yield data. View Sudarshan Pharma Industries dividend details including ex-dates and amounts for SUDARSHAN stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.30 4.05%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Sudarshan Pharma Industries Stock Index Membership

See which indices include Sudarshan Pharma Industries stock. Check SUDARSHAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sudarshan Pharma Industries is not part of any tracked indices.
Only major market indices are tracked in our system.

Sudarshan Pharma Industries Market Events Screener - Corporate Actions

Get Sudarshan Pharma Industries corporate actions including splits, bonuses, and buybacks. Check Sudarshan Pharma Industries stock events that may affect SUDARSHAN share price.
Announcement Date Record Date Event Type Information Price Impact
Extraordinary General Meeting NA 94.52%
Annual General Meeting NA -0.07%
2026-04-30 2026-04-30 Quarterly Result Announcement NA -0.96%
2026-01-28 2026-01-28 Quarterly Result Announcement NA -0.93%
2025-10-18 2025-10-18 Quarterly Result Announcement NA -2.36%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 0.00%
2025-08-11 2025-08-11 Extraordinary General Meeting NA 2.74%
2025-07-25 2025-07-25 Annual General Meeting NA -8.80%
2025-06-12 2025-06-12 Extraordinary General Meeting NA 4.14%
2025-04-24 2025-04-24 Quarterly Result Announcement NA -5.82%
2025-02-04 2025-02-04 Extraordinary General Meeting NA -19.06%
2024-11-23 Split 1:10 0.00%
2024-10-31 2024-10-31 Quarterly Result Announcement NA 9.01%
2024-02-05 2024-02-05 Extraordinary General Meeting NA 2.39%
2023-08-25 2023-08-26 Dividend ₹ 0.30 /share 20.74%

Sudarshan Pharma Industries Competitors Screener - Peer Comparison

Screen SUDARSHAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sudarshan Chemical Industries 7,886 -193.04 3,379 32.20% 60 63.24
Kiri Industries 2,368 0.52 855 14.72% 265 44.98
Indokem 1,690 901.29 169 -5.26% 2 55.80
Ultramarine & Pigments 1,191 14.71 775 9.57% 84 44.86
Shree Pushkar Chemicals 1,160 16.05 977 19.52% 74 48.28
Bodal Chemicals 941 19.53 2,012 14.55% 57 60.37
Sudarshan Colorants 864 19.47 781 -7.49% 43 60.24
Sudarshan Pharma Industries 830 34.58 703 38.51% 23 73.10
Bhageria Industries 682 14.95 874 45.27% 40 46.88
Vipul Organics 377 67.32 163 8.01% 4 49.57

Sudarshan Pharma Industries Company Announcements - News Screener

Screen SUDARSHAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-28 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-05-24 Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 By Listed Entities. -
2026-05-24 Outcome Of Board Meeting Held Today I.E. Thursday 21St May 2026 -
2026-05-24 Announcement under Regulation 30 (LODR)-Allotment -
2026-05-21 Update on board meeting -
2026-05-21 Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday 22Nd May 2026 -
2026-05-21 Email By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Announcement Dated 15/05/2026 -
2026-05-15 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-05-15 Board Meeting Outcome for Approval Of Upto U.S. $ 20000000 Of 8.00% Senior Unsecured Foreign Currency Convertible Bonds Due 2029 Of Sudarshan Pharma Industries Limited -
2026-05-12 Board Meeting Intimation for Meeting To Be Held On Friday May 15 2026 -
2026-05-08 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) -
2026-05-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-01 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) -
2026-04-30 Announcement under Regulation 30 (LODR)-Change in Management -
2026-04-30 Audited Financial Results For The Financial Year Ended 31-03-2026 -
2026-04-27 Board Meeting Intimation for Meeting Scheduled On Thursday April 30 2026 -
2026-04-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-30 Closure of Trading Window -
2026-02-26 Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Updates On GST Inspection Search And Seizure -